Syndax Pharmaceuticals, Inc

Viatris Inc, headquartered in New York, NY, is dedicated to improving global healthcare by providing high-quality medicines across a wide range of therapeutic areas, including both noncommunicable and infectious diseases. The company is committed to ensuring reliable access to treatments, empowering individuals to live healthier lives at every stage of life. With a focus on innovation and sustainability, Viatris brings together talented professionals who share a common goal of enhancing healthcare access worldwide. The company actively engages in research and development to deliver effective solutions that meet the diverse needs of patients globally. Generated from the website

Amneal Pharmaceuticals is a leading provider of essential medicines, dedicated to making healthy possible through the development of approximately 280 generic and specialty pharmaceuticals, as well as biosimilars. With a commitment to innovation, Amneal has received FDA approvals for key products, including treatments for migraine and Parkinson's disease. The company prioritizes patient access and community support, exemplified by its initiatives to increase availability of critical medications like Naloxone. Amneal's culture emphasizes collaboration and leadership, driving efforts to positively impact the lives of patients and their families. Generated from the website

Inspirna, Inc. is a clinical-stage biopharmaceutical company based in New York, NY, dedicated to developing innovative cancer therapeutics. Utilizing their proprietary RNA-DRIVEr platform, they identify previously unknown drivers of metastasis in common cancers, aiming to convert cancer into a manageable, chronic condition. With a focus on small molecules and biologics, Inspirna's pipeline includes first-in-class oral medications such as ompenaclid RGX-202 for RAS mutant colorectal cancer and abequolixron RGX-104 for non-small cell lung cancer and endometrial cancer. By providing practical treatment options that prolong survival without compromising patients' quality of life, Inspirna strives to make a significant impact in areas of high unmet need. Their commitment to clinical validation and scientific discovery positions them as a leading player in the field of cancer research and development.Generated from the website